Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880044 · ClinicalTrials.gov registry record · NA
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT04880044 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 132 participants.
The verdict
NCT04880044, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a method to detect Barrett's esophagus (BE) in individuals with a new office-based diagnostic test.
Interventions
- DIAGNOSTIC_TEST EsoCheck/EsoGuard (EC/EG)
- DIAGNOSTIC_TEST Esophago-gastro-duodenoscopy (EGD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2025-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04880044
The ClinicalTrials.gov registry entry for NCT04880044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EsoCheck/EsoGuard (EC/EG) is the first listed.
NCT04880044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04880044 about?
NCT04880044 is a clinical study titled "Detection of Barrett s Esophagus in Patients Without GERD Symptoms". The purpose of this study is to develop a method to detect Barrett's esophagus (BE) in individuals with a new office-based diagnostic test.
What is the current status of trial NCT04880044?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2022-01-05. Estimated completion is 2025-02-25.
What interventions are being tested in trial NCT04880044?
The interventions under investigation include: EsoCheck/EsoGuard (EC/EG) (DIAGNOSTIC_TEST), Esophago-gastro-duodenoscopy (EGD) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04880044?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.